Literature DB >> 2701417

Retinoblastoma: biology, presentation, and current management.

S S Donaldson1, L M Smith.   

Abstract

Retinoblastoma is an uncommon ocular tumor of childhood which accounts for 5% of childhood blindness. It serves as a prototype for understanding the genetics of childhood cancer. The identification of the retinoblastoma gene has provided an explanation for the differing features of hereditary and nonhereditary retinoblastoma, as well as the potential for secondary malignancies in the hereditary cases. Management decisions are based upon the potential for useful vision, and the extent of disease including whether one or both eyes are involved. As nearly all patients present with disease confined to the globe, local control is excellent and survival exceeds 85%. Goals of management are cure of the disease, preservation of vision, and early detection and treatment of secondary malignancies in the genetically susceptible group.

Entities:  

Mesh:

Year:  1989        PMID: 2701417

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  11 in total

1.  Pars plana ciliary epithelial proliferation in 13q deletion syndrome.

Authors:  Y Usui; N A Rao
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  [Recurrent uveitis of unknown origin in childhood].

Authors:  F Seidensticker; P I Foerster; E M Messmer; A Kampik; S R Thurau
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

Review 3.  Applications of monoclonal antibodies in the investigation, diagnosis, and treatment of retinoblastoma.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

4.  Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism.

Authors:  Sara Amitrano; Annabella Marozza; Serena Somma; Valentina Imperatore; Theodora Hadjistilianou; Sonia De Francesco; Paolo Toti; Daniela Galimberti; Ilaria Meloni; Francesco Cetta; Pietro Piu; Chiara Di Marco; Laura Dosa; Caterina Lo Rizzo; Giulia Carignani; Maria Antonietta Mencarelli; Francesca Mari; Alessandra Renieri; Francesca Ariani
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

5.  Retinoblastoma: CT and MRI.

Authors:  R G Beets-Tan; M J Hendriks; L M Ramos; K E Tan
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

6.  High expression of TAZ indicates a poor prognosis in retinoblastoma.

Authors:  Yiting Zhang; Chunyan Xue; Hongjuan Cui; Zhenping Huang
Journal:  Diagn Pathol       Date:  2015-10-13       Impact factor: 2.644

7.  Spectrum of mutations in the RB1 gene in Vietnamese patients with retinoblastoma.

Authors:  Nguyen Cong Kiet; Le Thai Khuong; Do Duc Minh; Nguyen Huynh Minh Quan; Phan Thi Xinh; Nguyen Ngoc Chau Trang; Nguyen Thanh Luan; Nguyen Minh Khai; Hoang Anh Vu
Journal:  Mol Vis       Date:  2019-04-04       Impact factor: 2.367

8.  SMAD6, positively regulated by the DNM3OS-miR-134-5p axis, confers promoting effects to cell proliferation, migration and EMT process in retinoblastoma.

Authors:  Hui Wang; Xiang Ji
Journal:  Cancer Cell Int       Date:  2020-01-22       Impact factor: 5.722

9.  Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma.

Authors:  Mary E Kim; Ashley Polski; Liya Xu; Rishvanth K Prabakar; Chen-Ching Peng; Mark W Reid; Rachana Shah; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.639

10.  Spectrum of germ-line RB1 gene mutations in Malaysian patients with retinoblastoma.

Authors:  Mohd Khairul Nizam Mohd Khalid; Yusnita Yakob; Rohani Md Yasin; Keng Wee Teik; Ch'ng Gaik Siew; Jamalia Rahmat; Sunder Ramasamy; Joseph Alagaratnam
Journal:  Mol Vis       Date:  2015-10-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.